Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study

الملخص EN

Introduction.

Glucose-regulated protein 78 (78 kDa, GRP78), which is also known as immunoglobulin heavy chain binding protein (BIP), is a major chaperone in the endoplasmic reticulum (ER).

The expression and clinical significance of GRP78 in the serum of non-small cell lung cancer patients have not yet been clearly described.

The aims of the present study were to investigate the expression of GRP78 in the serum of non-small cell lung cancer patients, the relationships with clinicopathological parameters, and the potential implications for survival.

Patients and Methods.

A total of 163 peripheral blood samples from non-small cell lung cancer patients were prospectively collected at the Department of Thoracic Surgery, Fudan University Shanghai Cancer, China.

Clinical characteristics data, including age, gender, stage, overall survival (OS) time, and relapse-free survival (RFS) time, were also collected.

Serum GRP78 levels were measured using a commercially available ELISA kit.

The associations between GRP78 levels and clinicopathological characteristics and survival were examined using Student’s t-test, Kaplan-Meier, or Cox regression analyses.

Results.

The mean ± standard error (SE) value of GRP78 was 326.5 ± 49.77 pg/mL.

This level was significantly lower compared with the level in late-stage non-small cell lung cancer patients (1227 ± 223.6, p=0.0001).

There were no significant correlations with the clinicopathological parameters.

No significant difference was found between high GRP78 expression and low GRP78 expression with regard to RFS (p=0.1585).

However, the OS of patients with higher GRP78 expression was significantly poorer (p=0.0334).

Conclusions.

GRP78 was expressed in non-small cell lung cancer patients and was highly enriched in late-stage lung cancer.

GRP78 may have an important role in the carcinogenesis of non-small cell lung cancer and may be a prognostic marker for non-small cell lung cancer.